Ligand Avinza Co-promotion Deal Adds 700 Reps; Goal Is 10% Share By 2008
Executive Summary
Ligand's Avinza co-promotion agreement with Organon adds more than 700 reps to detail the extended-release morphine product
You may also be interested in...
Akzo Nobel Pharma “Rough Ride” In 2004 Offset By Partnering, R&D Potential
Akzo Nobel hopes that partnering agreements and investment in R&D will help its pharmaceutical division weather the "rough ride" expected in 2004
Akzo Nobel Pharma “Rough Ride” In 2004 Offset By Partnering, R&D Potential
Akzo Nobel hopes that partnering agreements and investment in R&D will help its pharmaceutical division weather the "rough ride" expected in 2004
Teva’s Generic Remeron Exclusivity Cut To Five Months By FDA Rules
Teva's generic Remeron (mirtazapine) will have only five months of marketing exclusivity from its approval date due to FDA's current interpretation of the trigger for first-to-file 180-day marketing exclusivity under the Waxman/Hatch Act, Teva reported in its Feb. 18 earnings teleconference
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: